GE HealthCare Technologies Inc.’s stock slid 3.3% early Monday, after UBS downgraded the stock to sell from neutral and cut its price target to $66 from $86, warning of margin disappointments ahead.
Analysts led by Graham Doyle said a combination of a recent slowing of order momentum, tough comparables and a lack of pricing tailwinds has left them below consensus on certain earnings metrics. GE HealthCare was spun out of General Electric Co. in January and houses the company’s medical device business.
“Our…
Master your money.
Subscribe to MarketWatch.
Get this article and all of MarketWatch.
Access from any device. Anywhere. Anytime.
Subscribe Now
Already a subscriber?
Log In
Read the full article here
